MedTrace Logo

Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance

NCT01257633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2025-11-17

No results posted yet for this study

Summary

The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) laryngeal cancer.

Conditions

  • Laryngeal Neoplasms

Interventions

PROCEDURE

Transoral robot-assisted tumor resection using the da Vinci robot

Transoral robot-assisted tumor resection using the da Vinci robot

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Benjamin Lallemant, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257633 on ClinicalTrials.gov